Published in F1000Res on April 19, 2016
The lncRNA H19 Promotes Cell Proliferation by Competitively Binding to miR-200a and Derepressing β-Catenin Expression in Colorectal Cancer. Biomed Res Int (2017) 0.75
Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer. Cell Death Dis (2017) 0.75
Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment. Stem Cells Int (2017) 0.75
A New View of Pathway-Driven Drug Resistance in Tumor Proliferation. Trends Pharmacol Sci (2017) 0.75
E-cadherin expression increases cell proliferation by regulating energy metabolism through NF-κB in AGS cells. Cancer Sci (2017) 0.75
Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells. Int J Oncol (2017) 0.75
A reliable method for the sorting and identification of ALDH(high) cancer stem cells by flow cytometry. Exp Ther Med (2017) 0.75
FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases. Front Pharmacol (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature (2007) 29.32
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell (2002) 13.92
Crypt stem cells as the cells-of-origin of intestinal cancer. Nature (2008) 11.66
Linking colorectal cancer to Wnt signaling. Cell (2000) 11.58
NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer (2002) 11.39
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet (1998) 10.51
Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet (2008) 10.22
Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A (2001) 7.99
Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol (2011) 7.84
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol (2010) 7.73
Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell (2009) 7.08
Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet (2010) 6.81
Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science (2012) 6.55
Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev (2003) 6.27
Cancer stem cells: mirage or reality? Nat Med (2009) 5.20
Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci (2002) 4.92
Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature (2013) 4.83
The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell (2011) 4.79
Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci U S A (2003) 4.76
Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol (2007) 4.75
Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell (2012) 4.58
Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev (2005) 4.27
Interconversion between intestinal stem cell populations in distinct niches. Science (2011) 4.23
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature (2015) 4.18
Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A (2010) 3.94
The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell (2012) 3.91
The intestinal epithelial stem cell. Bioessays (2002) 3.82
The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci U S A (2011) 3.80
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature (2015) 3.77
The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J (2012) 3.70
Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer. Cell (2015) 3.54
Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A (2001) 3.51
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature (2012) 3.44
Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation (2003) 3.41
The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol (1997) 3.32
Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol (2012) 3.30
Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. Gut (2010) 3.24
The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest (2002) 3.23
Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol (2007) 3.06
The intestinal crypt, a prototype stem cell compartment. Cell (2013) 3.00
Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci (1998) 2.92
Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science (2014) 2.89
Active Wnt proteins are secreted on exosomes. Nat Cell Biol (2012) 2.81
Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature (2012) 2.76
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract (1998) 2.63
Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet (2002) 2.43
L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol (2005) 2.39
ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell (2013) 2.32
Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res (2007) 2.26
Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res (2003) 2.24
Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science (1996) 2.22
Patterning and growth control by membrane-tethered Wingless. Nature (2013) 2.06
beta-Catenin signaling in biological control and cancer. J Cell Biochem (2007) 1.89
Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell (2014) 1.88
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol (2015) 1.87
Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res (2002) 1.82
Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell (2011) 1.80
The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73
HOXA5 Counteracts Stem Cell Traits by Inhibiting Wnt Signaling in Colorectal Cancer. Cancer Cell (2015) 1.59
Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells (2012) 1.55
Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer (2008) 1.49
Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Sci (2010) 1.49
Sequential cancer mutations in cultured human intestinal stem cells. Nature (2015) 1.48
Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages. Proc Natl Acad Sci U S A (1997) 1.45
A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. Mol Cell Biol (2012) 1.34
STUDIES ON THE MORPHOGENESIS OF ADENOMATOUS POLYPS IN THE HUMAN COLON. Cancer (1963) 1.32
Stem cell dynamics in homeostasis and cancer of the intestine. Nat Rev Cancer (2014) 1.28
In situ validation of an intestinal stem cell signature in colorectal cancer. Gut (2012) 1.26
Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res (2011) 1.24
Distinct levels of Sox9 expression mark colon epithelial stem cells that form colonoids in culture. Am J Physiol Gastrointest Liver Physiol (2011) 1.23
The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation. J Cell Sci (2010) 1.21
Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci (2010) 1.15
Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review. Pathol Res Pract (2015) 1.15
Controversies in cancer stem cells: targeting embryonic signaling pathways. Clin Cancer Res (2010) 1.12
Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World J Surg Oncol (2012) 1.06
Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Ann Surg Oncol (2011) 1.05
The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression. Nat Cell Biol (2014) 1.03
Expansion of a mutated clone: from stem cell to tumour. J Clin Pathol (2007) 1.03
Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine. Oncogene (2010) 1.01
Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas. Int J Colorectal Dis (2009) 1.00
The gastrointestinal tumor microenvironment. Gastroenterology (2013) 0.99
NF-κB in colorectal cancer. J Mol Med (Berl) (2013) 0.95
Transformation of the intestinal epithelium by the MSI2 RNA-binding protein. Nat Commun (2015) 0.93
PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells. Cell Rep (2014) 0.92
Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance. Biomed Pharmacother (2014) 0.92
Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression. Oncogene (2012) 0.91
Prox1 promotes expansion of the colorectal cancer stem cell population to fuel tumor growth and ischemia resistance. Cell Rep (2014) 0.89
Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis. Oncotarget (2015) 0.81
The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC. Br J Cancer (2014) 0.80
Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression. Oncogene (2015) 0.80